Fate Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Fate Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Fate Therapeutics Inc
Rating: 1.77883325
Author: Trendlyne DVM scores

about

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is compri...

1.17 -0.13 (-10.00%)

79.65% Fall from 52W High

1.7M

XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

21.3 / 100

Technically Neutral

49.8 / 100

1Yr Price target upside is 380%

10 analysts

Fate Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Fate Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is compri...

79.65% Fall from 52W High

SWOT Analysis

Fate Therapeutics Inc Live Price Chart